SCHEMBL13182003

SCHEMBL13182003

CCCCC1CC(=O)CCC1C

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NOS1 P29475 6/20 0.35
NOS2 P35228 6/20 0.35
CYP1A2 P05177 4/20 0.35
NOS3 P29474 3/20 0.35
TP53 P04637 1/20 0.33
TLR4 O00206 1/20 0.32
NFKB1 P19838 1/20 0.32
NFKB2 Q00653 1/20 0.32
RELA Q04206 1/20 0.32
ALDH1A1 P00352 2/20 0.31
KDM4E B2RXH2 1/20 0.31
MEN1 O00255 1/20 0.31
MAPT P10636 1/20 0.31
PKM P14618 1/20 0.31
HPGD P15428 1/20 0.31
KMT2A Q03164 1/20 0.31
SHBG P04278 1/20 0.31
TDP1 Q9NUW8 1/20 0.30
POLB P06746 1/20 0.30
L3MBTL1 Q9Y468 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14441606 0.78 CYP1A2 (0.38) NOS1NOS2CYP1A2NOS3TP53
SCHEMBL9706580 0.76 CYP1A2 (0.38) CYP1A2TP53TLR4NFKB1NFKB2
SCHEMBL2693722 0.75 CYP1A2 (0.50) NOS1NOS2CYP1A2TP53TLR4
SCHEMBL6526063 0.75 CYP1A2 (0.50) NOS1NOS2CYP1A2TP53TLR4
SCHEMBL4548488 0.73 NOS1 (0.36) NOS1NOS2CYP1A2NOS3ALDH1A1
SCHEMBL5027240 0.73 TLR4 (0.38) CYP1A2TLR4ALDH1A1POLBL3MBTL1
SCHEMBL5027232 0.73 TLR4 (0.38) CYP1A2TLR4ALDH1A1POLBL3MBTL1
SCHEMBL9469634 0.72 ALDH1A1 (0.46) ALDH1A1KDM4EMEN1MAPTHPGD
SCHEMBL9470587 0.72 ALDH1A1 (0.46) ALDH1A1KDM4EMEN1MAPTHPGD
SCHEMBL9470580 0.72 ALDH1A1 (0.46) ALDH1A1KDM4EMEN1MAPTHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2010097479-A2 CYCLOHEXYL CARBAMATE COMPOUNDS AS ACTIVE ANTI-CELLULITE INGREDIENTS SYMRISE GMBH & CO. KG (DE) 2010-09-02 WO disclosed